Results

Total Results: 1,402 records

Showing results for "questions".

421. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/v1-breast-cancer-medications-for-risk-reduction--s
     May 06, 2002 - Further clinical trials are needed to answer these and other questions. … Important questions remain unanswered, and existing trials should continue. … The secondary questions (i.e., linkage questions), shown in the body of Figure A-1 (9 KB), are the … Therefore, this review focuses on Key Questions 2 through 5. … We consider in these questions evidence about issues of dose and duration of chemoprevention.

422. Chemo and Couns/2nd instal (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-hnLT26c2NHs6thK9yznPF
     July 01, 2002 - to guide the search.18 (Details about the framework, key questions, and search strategy can be found … Further clinical trials are needed to answer these and other questions. … Important questions remain unanswered, and existing trials should continue. … The secondary questions (ie, linkage questions), shown in the body of Figure 1, are the following: 2 … Therefore, this review focuses on Key Questions 2 through 5.

423. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
     May 06, 2002 - Further clinical trials are needed to answer these and other questions. … Important questions remain unanswered, and existing trials should continue. … The secondary questions (i.e., linkage questions), shown in the body of Figure A-1 (9 KB), are the … Therefore, this review focuses on Key Questions 2 through 5. … We consider in these questions evidence about issues of dose and duration of chemoprevention.

424. Evidence Summary: Screening for Dyslipidemia in Younger Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-dyslipidemia/statin-use-in-adults-preventive-medication
     November 13, 2016 - Scope of the Review Using established methods 16 , 17 the USPSTF determined the scope, key questions … protocol was developed and publicly posted on the USPSTF Web site before the review was carried out Key questions … worked with USPSTF members and AHRQ staff to develop and refine the scope, analytic framework, and key questions … screening strategies (Key Question 3), followed by the effect of treatment on health outcomes (Key Questions … the screening and treatment areas of the framework represent the assessment of associated harms (Key Questions

425. Archived: Evidence Summary: Screening for Dyslipidemia in Younger Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-dyslipidemia/statin-use-in-adults-preventive-medication-november-2016
     November 13, 2016 - Scope of the Review Using established methods 16 , 17 the USPSTF determined the scope, key questions … protocol was developed and publicly posted on the USPSTF Web site before the review was carried out Key questions … worked with USPSTF members and AHRQ staff to develop and refine the scope, analytic framework, and key questions … screening strategies (Key Question 3), followed by the effect of treatment on health outcomes (Key Questions … the screening and treatment areas of the framework represent the assessment of associated harms (Key Questions

426. Evidence Summary: Pancreatic Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/pancreatic-cancer-screening
     August 06, 2019 - For key questions on screening (KQ1, KQ2, KQ3), the population of interest was adults 18 years or older … , since no biomarkers have been validated as screening tests at the time of the review. 9 For key questions … nvestigators worked with USPSTF members and AHRQ staff to develop the scope, analytic framework, and key questions … the US Preventive Services Task Force (USPSTF) use an analytic framework to visually display the key questions … The questions are depicted by linkages that relate interventions and outcomes.

427. Evidence Summary: Speech and Language Delay and Disorders in Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/speech-and-language-delay-and-disorders-in-children-age-5-and-younger-screening
     January 23, 2024 - evidence review. 12 In addition to the KQs, this review looked for evidence related to 3 contextual questions … Analytic Framework and Key Questions: Screening for Speech and Language Delay and Disorders in Children … The questions are depicted by linkages that relate interventions and outcomes. … 6 y and 11 mo Comprehension of vocabulary (nouns, verbs, prepositions, conjunctions), syntax (WH questions … observation 105 g 10 100 (72-100) 81 (71-88) 38 100 5.2 0    ≥3 Comprehension questions

428. Final Research Plan: Sexually Transmitted Infections: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/sexually-transmitted-infections-behavioral-counseling
     August 02, 2018 - Key Questions to Be Systematically Reviewed … Contextual Questions The … Criteria are overarching as well as specific to each of the key questions (KQs).  

429. Current Processes of the U.S. Preventive Services Task Force: Refining Evidence-Based Recommendation Development (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/currprocess.pdf
     July 01, 2007 - A full evidence update systematically examines a complete analytic framework of key questions by using … Full evidence reviews begin with the development of an analytic framework of key questions followed by … For this review, the Task Force asked the EPC to report results for a limited number of key questions … , and then determined whether the remaining key questions needed to be system- atically reviewed in order … Update key questions are critical ques- tions whose answers might result in the USPSTF making a different

430. Serologic Screening for Genital Herpes: An Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/aHpXYasjc3n6zhaTtoWMwK
     August 01, 2016 - Analytic Framework and Key Questions Key questions 5 a. … the US Preventive Services Task Force (USPSTF) use an analytic framework to visually display the key questions … The questions are depicted by linkages that relate interventions and outcomes. … b Key question 7 will be addressed only if there is insufficient literature for key questions 1 and 5 … Therefore, the literature that might establish an indi- rect chain of evidence from multiple questions

431. Evidence Summary: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/impaired-visual-acuity-in-older-adults-screening
     March 01, 2016 - Scope of the Review Using established methods, 11 the USPSTF determined the scope and key questions … The analytic framework and key questions (KQs) used to guide the review are shown in Figure 1 . … We included studies of diagnostic accuracy of vision screening tests, questions, or questionnaires performed … Analytic Framework and Key Questions “Asymptomatic” individuals are those without known impaired … Poor Key question 3: Accuracy of screening Four studies found screening questions are not accurate

432. Archived: Evidence Summary: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/impaired-visual-acuity-in-older-adults-screening-2016
     March 01, 2016 - Scope of the Review Using established methods, 11 the USPSTF determined the scope and key questions … The analytic framework and key questions (KQs) used to guide the review are shown in Figure 1 . … We included studies of diagnostic accuracy of vision screening tests, questions, or questionnaires performed … Analytic Framework and Key Questions … Poor Key question 3: Accuracy of screening Four studies found screening questions are not accurate

433. Draft Research Plan: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/osteoporosis-screening-prevent-fractures
     August 12, 2021 - Proposed Key Questions to Be Systematically Reviewed … Proposed Contextual Questions … Contextual questions will not be systematically reviewed and are not shown in the Analytic Framework

434. Screening for Gonorrhea: Update of the Evidence (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Wezro6zTSfAWxCrneF-nxB
     May 01, 2005 - Conclusions: Recent evidence only addresses key questions about risk factors and new tests. … These include: Key Questions: Asymptomatic Men and women including adolescents 1A. … Key Questions: Pregnant women 1A. … Key Questions: Newborn chemoprophylaxis 1. … No new evidence was identified to address key questions for pregnant women and newborns.

435. Screening for and Treatment of Suicide Risk Relevant to Primary Care: A Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/vxPM4Bo9RXZGUDH6MWnDht
     May 01, 2013 - For questions related to harms and benefits of screen- ing or treatment, we included randomized and nonran … For key questions 4 and 5 only, we conducted random-effects meta-analyses to estimate the effect size … We in- cluded 7 trials that addressed screening (key questions 1, 2, and 3): 1 examined short-term benefits … We included 49 trials that addressed the benefits of treatment (key questions 4 and 5)—36 were conducted … The Table summarizes the evidence from this review for all key questions.

436. Draft Research Plan: Depression, Anxiety, and Suicide Risk in Adults, Including Pregnant and Postpartum Persons: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/screening-depression-anxiety-suicide-risk-adults
     May 07, 2020 - Proposed Analytic Framework Proposed Key Questions to Be Systematically Reviewed … Proposed Contextual Questions Contextual questions will not be systematically reviewed and are … Criteria are overarching as well as specific to each of the key questions.  

437. Draft Research Plan: Depression and Suicide Risk in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/screening-depression-suicide-risk-adults
     May 07, 2020 - Proposed Key Questions … Proposed Contextual Questions … Contextual questions will not be systematically reviewed and are not shown in the Analytic Framework … Criteria are overarching as well as specific to each of the key questions.  

438. Draft Research Plan: Anxiety in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/anxiety-adults-screening
     May 07, 2020 - Proposed Key Questions … Proposed Contextual Questions … Contextual questions will not be systematically reviewed and are not shown in the Analytic Framework … Criteria are overarching as well as specific to each of the key questions.  

439. Benefits and Harms of Prostate-Specific Antigen Screening for Prostate Cancer: An Evidence Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/NhXnjZM5ubvygH5GrqDZHC
     August 01, 2008 - harms and of the natural history of screening-detected cancer were selected to answer the following questions … The analytic framework that guided the previous USPSTF evidence review (Figure) (12) included 8 key questions … These evidence gaps produced 3 new key questions for this update: 1. … Data from the 2002 USPSTF review (12) relevant to key questions 1 and 2 are included to facilitate an … mostly college- educated 6 wk, 6 mo, and 1 y after testing: survey developed in focus groups with questions

440. Evidence Summary: Thyroid Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/thyroid-cancer-screening
     May 09, 2017 - For screening questions (KQ1 through KQ3), any studies of asymptomatic adult populations were included … For treatment questions (KQ4 and KQ5), any studies of thyroid surgery (complete thyroidectomy, near-total … The questions are depticted by linkages that relate interventions and outcomes. … The full text of 707 citations were examined for inclusion for one or more of the eight Key Questions … , or for contextual questions.